Ardent Health (ARDT) Could Be 4% Undervalued As Digital Leadership Comes Into Focus

Ardent Health (ARDT) is back in focus after the company named Gaurav Khanna as chief digital and information officer, a leadership move that places technology, data, AI, and digital strategy squarely on investors’ radar.

Recent trading tells a mixed story. Ardent Health’s share price return is up 13.67% over the past 30 days and 39.58% year to date, yet the 1-year total shareholder return is down 18.73%. This suggests that improving momentum is still working against an earlier, weaker period.

Scan other hospital and healthcare operators showing strong digital leadership by reviewing the list of solid balance sheet and fundamentals (25 results), which may complement your view on Ardent Health.

Bulls point to Ardent Health’s new digital leadership and recent share price rebound, while bears highlight the weaker 1 year return and value score. Which side do the current valuation signals lean toward?

Most Popular Narrative: 4% Undervalued

The most followed valuation narrative for Ardent Health pegs fair value at $12.50, slightly above the last close of $12.06. This puts recent price strength up against measured optimism about fundamentals.

The accelerated deployment of advanced technology, including AI-enabled scribe tools, virtual nursing, and digital wearables, improves clinical efficiency, reduces labor costs, limits nurse turnover, and streamlines workflow, all of which bolster operational efficiency and EBITDA margins. The company's disciplined balance sheet management and ability to pursue strategic acquisitions and partnerships in attractive markets allow Ardent to capitalize on industry consolidation, expanding its scale and mitigating regulatory headwinds, ultimately supporting both revenue growth and margin expansion.

See why 1 investors see Ardent Health as 4% undervalued.

Result: Fair Value of $12.50 (UNDERVALUED)

Still, the narrative can break if regulatory changes cut into Medicaid support, or if payer denials and reimbursement disputes again drag on Ardent Health’s earnings.

Find out about the key risks to this Ardent Health narrative.

Another View: Ardent Health Through A Cash Flow Lens

A different lens on Ardent Health comes from the SWS DCF model, which points to a future cash flow value of $2.63 per share. With the stock at $12.06, that framework flags the shares as expensive rather than 4% undervalued. Which story do you trust more: cash flows or the current earnings based narrative?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ardent Health for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 33 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals or a clear opportunity, only you can decide which story around Ardent Health carries more weight for your portfolio. Act while the data is fresh and pressure test your own view against the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Ardent Health?

If Ardent Health has you thinking harder about where risk and reward really line up, do not stop with a single ticker. Broaden your watchlist with ideas grounded in data and let the numbers challenge your assumptions before the next move in the market.

• Target potential value opportunities by reviewing the 33 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect them yet.
• Strengthen your income stream by scanning the 7 dividend fortresses that focus on higher yields with an emphasis on resilience.
• Protect your downside by filtering for the 31 resilient stocks with low risk scores that aim to keep volatility in check while still offering meaningful exposure.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com